ICE Pharma Sites in Basaluzzo and Reggio Emilia Obtain Authorized Economic Operator (AEO) Status
ICE Pharma is pleased to announce that its Basaluzzo and Reggio Emilia sites have successfully obtained Authorized Economic Operator (AEO) status from the Italian Customs and Monopolies Agency (Agenzia...
Raichem Strengthens Community Support in Raichur with Clean Water and Food Initiatives
Reinforcing its commitment to corporate social responsibility and community welfare, Raichem has launched two impactful initiatives in Raichur, Karnataka, addressing critical challenges related to access to clean drinking water...
Corporate Social Responsibility in the Pharmaceutical Industry: Advancing Global Health Through Sustainable Impact
In the evolving landscape of the B2B pharmaceutical industry, companies are expected to deliver more than high-quality products and services. Today, corporate social responsibility (CSR) and ESG in pharma...
Strengthening Sustainability Through Verified Carbon Footprint Certification
Our company has achieved ISO 14067 certification for Carbon Footprint verification, marking a significant milestone in our sustainability journey and reinforcing our commitment to responsible pharmaceutical manufacturing. With this...
New Zealand Pharmaceuticals Achieves Recertification for ISO 14001, ISO 45001, ISO 14064-1, and ISO 50001
New Zealand Pharmaceuticals (NZP) has successfully completed its recertification and annual audits for four major international standards:ISO 14001 (Environmental Management), ISO 45001 (Health & Safety Management), ISO 14064-1 (Greenhouse...
Bile Acids: A Promising Class of Functional Excipients in Modern Drug Delivery
We are proud to share our latest contribution to the field of specialty chemicals, where we explore the promising role of bile acids (BAs) as functional excipients in drug...
Basaluzzo Site Renews GMP Certification from AIFA Until 2028
We are proud to announce that the Basaluzzo site has successfully renewed its GMP (Good Manufacturing Practice) certification issued by AIFA, the Italian Medicines Agency. This renewed authorization is...
ICE Pharma Inaugurates New F Block at Raichem (India), Boosting UDCA Production from Chicken Bile
ICE Pharma is proud to announce the inauguration of the new F Block at Raichem, our subsidiary in India — a strategic investment aimed at expanding production capacity and...
Improving Solubility and Bioavailability with Bile Acids
Can nature’s own surfactants unlock the next generation of drug delivery? In a new interview, ICE Pharma’s Chief Commercial Officer, Roger Viney, discusses how bile acids are transforming the...
New state-of-the-art warehouse inaugurated at ABC Farmaceutici site of Ivrea
This April, a new state-of-the-art warehouse was officially inaugurated at ABC Farmaceutici in Ivrea. This highly technological facility is the result of a major investment aimed at enhancing our...
Opening of a new warehouse in ICE Japan site
In a remarkable journey that began with the start of constructionin in February 2024, we are thrilled to announce the successful opening of our state-of-the-art fully automatic warehouse on...
ICE Pharma 2023/2024 Sustainability Report
At ICE Pharma, our commitment to sustainability is reflected in a strategy that balances ambition with practical, achievable steps. As we navigate a rapidly evolving industry, we understand that...